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Abstract 
The nutrients are able to interact with molecular mechanisms and modulate the physiological functions in the body. The 
Nutritional Genomics focuses on the interaction between bioactive food components and the genome, which includes 
Nutrigenetics and Nutrigenomics. The influence of nutrients on f genes expression is called Nutrigenomics, while the 
heterogeneous response of gene variants to nutrients, dietary components and developing nutraceticals is called Nutrigenet-
ics. Genetic variation is known to affect food tolerances among human subpopulations and may also influence dietary 
requirements and raising the possibility of individualizing nutritional intake for optimal health and disease prevention on the 
basis of an individual’s genome. Nutrigenomics provides a genetic understanding for how common dietary components af-
fect the balance between health and disease by altering the expression and/or structure of an individual's genetic makeup. 
Nutrigenetics describes that the genetic profile have impact on the response of body to bioactive food components by 
influencing their absorption, metabolism, and site of action.  
In this way, considering different aspects of gene–nutrient interaction and designing appropriate diet for every specific 
genotype that optimize individual health, diagnosis and nutritional treatment of genome instability, we could prevent and 
control conversion of healthy phenotype to diseases. 
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Introduction 
With the completion of human genome sequenc-
ing and entering the-Omics area, the new term 
"Nutritional Genomics" tends to replace the for-
mer "nutrient-gene interactions" (1). It has been 
demonstrated that numerous genetic polymor-
phisms can influence protein structure function. 
The Nutritional genomic area includes two parts: 
first Nutrigenomics that is the study of interaction 
between dietary components and the genome, and 
the regulating changes in proteins and other me-
tabolism; second Nutrigenetics that identify the 
response to dietary components with regard to 
genetic differences (2).  
Nutrients are as environmental factors can inter-
act with genetic material. It has been clearly dem-
onstrated that DNA metabolism and repair de-
pend on a wide range of dietary factors that act 
as cofactors or substrates in metabolic pathway, 
but much less is known about the impact of 
cofactors and/or micronutrients deficiency or ex-
cess on the fidelity of DNA replication and re-
pair (3). Although the nutrients can influence the 
development of a particular phenotype, the re-
sponse to a specific nutrient that determined by the 
individual genotype has also to be considered 
(Fig. 1).  
The central role of genetic code in determining 
genome stability and related health outcomes such 
as developmental defects, degenerative diseases, 
and cancer is well-established (4). The etiology 
of complex chronic diseases obviously relates to 
both environmental and genetic factors (5). Spe-
cifically, the "fetal basis of adult disease" or "early 
origins hypothesis" postulates that nutrition and 
other environmental factors during prenatal and 
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early postnatal development influence gene ex-
pression and cellular plasticity, which can alter 
susceptibility to adult diseases (cardiovascular dis-
eases, diabetes, obesity. etc) (6).   
The concept of nutrients effects on DNA stability, 
repair and on the different gene expression proc-
esses, recently became more prominent in nu-
tritional science (7). Numerous dietary compo-
nents can alter genetic and epigenetic events and 
therefore influence health (8). 
SNPs (single nucleotide polymorphisms) are the 
most common genetic variation, occur at about 
500-2000 bp throughout the human genome, and 
normally found in at least 1% of the population 
(5). Many human studies have demonstrated the 
evidence for interaction between SNPs in vari-
ous genes and the metabolic response to the diet. 
Moreover, SNPs analysis provides a potential 
molecular tool for investigating the role of nutri-
tion in human health, diseases and identification 
of optimal diets (9) 
Nutrients and genome interact at two levels: 1) 
Nutrients can induce or repress gene expression 
thereby altering individual phenotype. 2) Conver-
sely, single nucleotide polymorphisms can alter 
the bioactivity of important metabolic pathways and 
mediators and influence the ability of nutrients 
to interact with them (Fig. 1). 
 
 
Polymorphic and Mutant Genes 
(Changed enzymatic and hormonal activities) 
 
 
Macronutrients (proteins, lipids, etc) 
Micronutrient (minerals, vitamins, etc) 
 
Fig.1: Nutrigenomics and Nutrigenetics are resulted from genes and nutrients interaction. 
 
 
Genetic responses involve: effect on genome evolution, mutation, selection, programming, viability, gene expression, 
chromosome stability, signal transduction and metabolic pathways, protein synthesis and structure, epigenetic events, 
chronic diseases. 
Nutritional responses involve: effect on nutrients absorption, nutrients utilization and requirement, food/nutrient tolerance, 
and food atopies 
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Nutritional Genomics 
The interaction between the nutrients and cellu-
lar/genetic processes is being referred to as 
"nutritional Genomics" (10). This term describes 
the interface of biochemistry genomics, human 
nutrition, understanding of reactions and interac-
tions at the molecular genomic levels (11). The 
conceptual basis for this genomic research can 
be summarized with the following five princi-
ples: 1) Common dietary chemicals act on the 
human genome, either directly or indirectly, to 
alter gene expression and/or structure. 2) Under 
certain circumstances and in some individuals, 
diet can be a serious risk factor for a number of 
diseases. 3) Some diet-regulated genes (and their 
normal, common variants) are likely to play a 
role in the onset, incidence, progression, and/or 
severity of chronic diseases. 
4) The degree to which diet influences the bal-
ance between healthy and disease states may de-
pend on an individuals genetic background. 5) 
Dietary intervention based on knowledge of indi-
vidual nutritional requirement, nutritional status, 
and genotype (i.e., “individualized nutrition") can be 
used to prevent, relieve, or cure chronic disease. 
 
Nutrigenetics  
Nutrigenetics term was used first time by Dr 
R.O Brennan in 1975 in his book Nutrigenetics 
(12). Nutrigenetics points to understanding how 
the genetic background of an individual impact 
to the diet (13). 
The study of gene-nutrient interaction is a devel-
oping area of science. This idea that adverse 
diet/genome interaction can cause disease is not 
new and the unsuitable diet for any individual 
genotype could be a risk factor for monogenetic 
and polygenetic disease (10, 14). Genetic polymor-
phisms can influence response to environmental 
elements, such as enzymatic activities changes that 
affect circulating concentrations and ultimately the 
effectiveness of chemicals and their metabolites 
(5). Furthermore, metabolic disorders are other 
examples of influence of the genetic variations to 
diet such as PKU, defects associated with long 
chain fatty acid oxidation, iron absorption (haemo-
chromatosis), which can be reasonably well man-
aged with dietary restrictions (15).  
As mentioned earlier SNPs study can be catego-
rized in the field of Nutrigenetics. Some specific 
examples of the association between SNPs and 
specific food components such as enzymes defi-
ciency are reviewed in this article. For example, 
different mutations in galactose-1-phosphate uridyl-
transferase (GALT) gene (14-18), phenylalanine 
hydroxylase gene (19, 20), and Glucose-6-phos-
phate dehydrogenize (G6PD) gene (21-24) resulted 
in Galactosemia, Phenylketonuria (PKU), and 
Favism diseases, respectively. Other examples of 
enzymes polymorphisms include Lactase-phlorizin 
hydrolase gene (LPH) polymorphisms that show 
how SNPs alter gene expression. This polymor-
phism is in the upstream of the lactase-phlorizin 
hydrolase gene (LPH) associated with hypolactasia 
and changes tolerance to dietary lactose (milk 
sugar, LPH hydrolyzes lactose into glucose and 
galactose) and allows different expression of the 
LPH (25, 26). 
Glutathione peroxide gene polymorphism is an-
other example. The association between selenium 
supplementation and reduced incidence of liver, 
colon, prostate, and lung cancer in human has been 
shown. However, no individuals may respond 
equally. Glutathione peroxide is a selenium-de-
pendent enzyme that acts as an antioxidant en-
zyme. Polymorphism at codon 198 of human 
glutathione peroxides results in a subsituation of 
proline to leucine amino acid, and has been 
associated with an increase risk of lung cancer. 
Investigators shown that persons with (Pro/Lue) 
genotype were at 80% greater risk for lung cancer 
and (Lue/Lue) genotypes were at 130% greater 
risk compared risk those with the (Pro/Pro) 
genotype. The leucine-coding allele was less re-
sponsive to increased activity because of sele-
nium supplementation as compared with the prolin-
containing allele (8). 
Manganese super oxide dismutase (MnSOD) is 
a mitochondrial enzyme that plays a key role in 
detoxification of reactive oxygen species. A poly-
morphism valine to alanin subsituation in in this 
enzyme alters its transport into mitochondria, 
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which has been associated with increased risk of 
breast cancer (8). 
Methylen tetrahydrofulate redoctase (MTHFR) 
enzyme catalyzes the reaction that produces 5-
methyl tetrahydrofolate. The one-carbon units 
are carried on N-5 or N10 of tetrahydrofolate. 
One-carbone metabolism is needed for the de-
novo synthesis of purine nucleotides and thymidi-
late and for the remethylation of homocyisteine to 
methionine. With methionine adenylation S-adeno-
sylmethionine (SAM) is formed, which is a co-
factor for numerous methylation reactions such 
as DNA methylation that affect gene regulation 
(27). For the MTHFR gene tow important SNPs 
has been well recognized: C677T (cytosine-to-
thymidine subsituation resulting in the conversion 
of an alanine to valine) and A1298C (adenine-
to-cytosine subsituation resulting in the conversion 
of an alanine to glotamic acid). The C677T poly-
morphism is the most common variant that occurs 
as homozygous T/T in 5-10% of the and as het-
erozygous C/T genotypes up to 40% general po-
pulation (28). The presence of C677T or A1298C 
mutations is associated with reduction in MTHFR 
enzyme activity and impairs folate accumulation, 
which may cause increases homocysteine concen-
tration in plasma, a risk factor for venous throm-
boembolic and ischemic arterial diseases (2). 
Another polymorphism of MTHFR gene is 
Ala222Val that affects folate metabolism.  It in-
creases the conversion of dUMP to dTMP and 
leads to more folate-dependent thymidine biosyn-
thesis and folate deficiency (27). This polymor-
phism is a risk factor for spontaneous abortions 
and decreased fetal viability, thus maternal folate 
supplementation can be useful for individuals with 
this polymorphism (29).  
MTHFR is also involved in maintenance genomic 
CpG methylation patterns and prevention of DNA 
strand breaks, these mutations are associated with 
increased risk of neural tube defects and some 
types of cancer (27). 
Changes in the concentration of folate (the MTHFR 
substrate) and riboflavin (the MTHFR cofactor) 
can modulate the activity of MTHFR gene (28). 
Generally, folic acid supplementation can help 
the negative health effect of these SNPs with de-
crease in plasma homocysteine levels (2, 27, 28). 
Enzymes that utilize and metabolize vitamin B12 
have been associated with NTDs, increased risk 
of Down syndrome and colon cancer. For ex-
ample, a common polymorphism in the HFE gene 
(Cys282Tyr) is associated with iron storage disease 
hereditary haemochromatosis, leading to an iron 
accumulation in the liver, heart and endocrine 
glands. This protein is an important regulator of 
cellular iron homeostasis and has role in intestinal 
iron absorption by regulating the interaction of 
the transferrin receptor with transferrin (27).  
Cytochrome P450s (CYPs) enzymes play a cen-
tral role in the oxidative biotransformation of ster-
oids, prostaglandins, nutrients, drugs, chemicals 
and carcinogens. Several dietary factors can alter 
the expression of CYP isoforms. CYP1A2 plays 
an essential role in the metabolism of wide range of 
drug and chemical substances. For example, 
CYP1A2 activates dietary carcinogens such as 
aromatic amines, but also detoxifies compounds 
such as caffeine. Low-activity CYP1A2 genotype 
with an increased risk of myocardial infarction 
suggests that this enzyme detoxify a substance, 
which may be an important risk factor in the po-
pulation. Indeed, individuals with a low-activity 
CYP1A2 genotype are at a greater risk of cof-
fee-associated heart disease. As caffeine is the 
main substance in coffee and is detoxified by 
CYP1A2, it may be an important risk factor for 
heart disease in certain population (5).  
Glutathione S transferase (GST) enzyme is a su-
perfamily of enzymes that play an important role 
in the detoxification of several dietary compounds. 
GSTM1, GSTT1 and GSTP1 are isoforms of this 
enzyme. The GSTM1 and GSTT1 null genotype 
have been associated with both an increased and 
a decreased risk of some types of cancers such 
as breast cancer (5, 30). Some components such 
as dietary isothiocyanates that are found in cruci-
ferous vegetables are eliminated with GSTs en-
zymes. Indeed, protective effect of the GSTM1 
null genotype on colon and lung cancer has been 
related to lower urinary excretion of glutathione-
conjugated phytochemicals indicating they are not 
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rapidly excreted. GSTT1 plays a similar role to 
GSTM1 in eliminating beneficial phytochemicals 
found in cruciferous vegetables. Moreover, in ve-
getables rich in phytochemicals such as isothio-
cyanates the expression of GSTs is increased 
conjugating them to more water-soluble forms 
that are easily excreted (5). 
Endothelial nitric oxide synthase (eNOS) is syn-
thesized from the amino acid L-argenine by NO 
synthase (NOS). The eNOS is expressed in the 
endothelium and produces NO that diffuses to 
vascular smooth muscle cell, where it increases 
the concentration of cGMP, leading to vascular 
relaxation. NO has central role in the pathogenesis 
of coronary spasm and atherogenesis. Several 
polymorphisms of eNOS may be associated with 
specific phenotype. For example, a Glu298Asp 
polymorphism in the eNOS gene has been associ-
ated with ischemic heart disease, myocardial in-
farction, and coronary spasm (30).  
Genetic polymorphisms in catechol-O-methyltrans-
ferase, sulfotransferase, and UDP-glucuronosyl-
transferase result in differences in enzymatic ac-
tivity. These enzymes metabolize some of dietary 
compounds. For example, green tea was associ-
ated with a lower risk of breast cancer only in 
women with the low-activity allele for catechol-
O-methyltransferase. This enzyme catalyzes the me-
thylation of catechins (a polyphenolic antioxidant 
plant secondary metabolite) in green tea making 
them more quickly eliminated (5).  
Apolipoprotein E (ApoE) gene has three differ-
ent alleles (ε2, ε3, ε4). Persons with ε4 variant 
respond to a high-fat diet negatively with an in-
creased risk for coronary heart disease (CHD). 
In these individuals, low-fat diet should be use-
ful (2). Moreover, there is an important relation-
ship between allelic variants in the ApoA1/C3/ 
A4/A5 genes and the effect of dietary fats on 
lipoprotein metabolism and CVD (cardio vascular 
diseases) risk. Linkage disequilibrium within Apo 
A1/C3/A4/A5 cluster has been represented to 
affect plasma lipid concentration and CVD risk. 
Apolipoprptein A-1 is and is a key component 
of high-density lipoprotein particles (HDL). The 
locus of gene encoding APOA-1 is on chromo-
some 11q and highly polymorph and has a 
specific SNP in its promoter region (19, 20). An 
Adenin/Guanin subsituation in the promoter region 
(-75bp) of the ApoA1 gene is common in differ-
ent populations. The presence of A allele (A/A 
and A/G) has been associated with incresed HDL-
cholesterol. Moreover, mild increase in APOA-1 
concentrations in subjects with the G/G geno-
type was observed (28, 30). APOA-5 gene is 
also an important regulator of triglyceride (TG)-
rich lipoprotein (TRL) metabolism (30). 
One of the Vitamin D receptor (VDR) polymor-
phism is Fok1. Individuals with F allele have three 
amino acids more than those without F allele in 
their VDR. The Ff or ff genotype is associated 
with 51% and 84% greater risk of colorectal 
cancer, respectively. Individuals that consumed 
low calcium and fat diet have more than double 
risk of colorectal cancer, specifically in persons 
with ff genotype rather than Ff genotype (8). 
VDR polymorphisms have been also associated 
with childhood and adult's asthma (27). 
Peroxisome proliferator-activated receptors (PPARs) 
are nuclear receptor supper family that plays an 
essential role in fatty acid oxidation, glucose, and 
extracellular lipid metabolism. PPARs are the 
best-known fatty-acid-regulated nuclear receptors. 
One of the three members of the PPARs family 
regulates many genes involved in fatty acid me-
tabolism. PPR-α (PPARA) plays a central role in 
lipid oxidation and inflammation, whereas PPAR-γ 
is involved in adipocytes differentiation, glucose 
and lipid storage, and inflammation. PPAR-δ 
(also known as PPAR-β), may has a crucial role 
in development, lipid metabolism, and inflam-
mation. These receptors bind to fatty acid and 
regulate the expression of genes involved in fatty 
acid transport and metabolism. PPARs family also 
involve in activation of about 300 genes (31).  
The PPAR-α gene has a polymorphism at codon 
162 (Lue162Val) that has been associated with 
changes in total cholesterol, LDL-associated cho-
lesterol, and Apo B concentrations. The less 
common V162 allele is associated with signifi-
cantly higher serum concentration of total cho-
lesterol, LDL cholesterol, Apo B, and Apo C-III 
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than in carriers of L162 allele, especially in men 
(20). For individuals with the common L162 
allele, increased intake of polyunsaturated fatty 
acids (PUFAs) had little effect on fasting tria-
cylglycerol concentrations. In those with the less 
common V162 allele, however, fasting triacyl-
glycerol concentrations fell abundantly with in-
creasing PUFA intake (32).  
 
Nutrigenomics 
Nutrigenomics aims to identify the effects of 
several nutrients, including macronutrients and 
micronutrients on the genome (13) and explores 
the interaction between genes and nutrients or 
food bioactives and their effects on human health 
(33). The influence of nutrients on the transcription 
activity, gene expression, and heterogeneous re-
sponse of gene variants is also referred to as "Nutri-
genomics". 
Nutrigenomics also describes the use of func-
tional genomic tools to study a biological system 
to understanding of how nutritional molecules 
affect metabolic pathways and homeostatic con-
trol. This branch of science will reveal the opti-
mal diet form within a series of nutritional changes, 
whereas Nutrigenetics will yield critically important 
information that assist clinicians in identifying 
the optimal diet for a given individual, i.e. per-
sonalized nutrition (13). Transcriptomics, proteo-
mics, and metabolomics are also technologies 
that apply in Nutrigenomics research (33). 
According to numerous studies, nutrients can al-
ter the expression of genes at the level of gene 
regulation, signal transduction, chromatin struc-
ture and protein function (33). 
Epidemiological studies show association between 
food intake and the incidence and severity of 
chronic diseases (34, 35). A large number of nu-
trition related pathologies (obesity, metabolic syn-
dromes, type 2 diabetes, CVD, and some types 
of cancers) are polygenic and multifactorial and 
their onset and progression are related to multiple 
genes and their variants as well as several en-
vironmental factors, especially the diet (30).  
Dietary chemicals can affect gene expression di-
rectly or indirectly. At the cellular level nutrients 
may act as ligands for transcription factor re-
ceptors (36, 37) or be metabolized by primary or 
secondary metabolic pathways, thereby altering 
concentrations of substrates or intermediates, and 
finally positively or negatively affect signal path-
ways (38-40).  
Transcription factors (TFs) are one of the key 
molecules through with nutrients can alter the 
gene expression. One of the most important groups 
of nutrient sensors is PPARs TFs with 48 
members in the human genome. The majority of 
receptors in this superfamily bind nutrients, their 
metabolites, and influences expression of spe-
cific genes involved in numerous metabolic proc-
ess in the liver, including fatty acid oxidation, 
ketogenesis, gluconeogenesis, amino acid metabo-
lism, cellular proliferation, and acute-phase re-
sponse (41). For example, the fatty acids palmitic 
(16:0), oleic (18:1n9), linoleic (18:2n6), and ara-
chidonic acid (20:4n6) (42-45), and the eico-
sanoids, 15deoxy-δ12, 14prostaglandinJ2 and 8-
(S) hydroxyeicosatraenoic acid, are ligands for 
PPAR-δ (46-48). These nuclear receptors act as 
sensors for fatty acids. Lipid sensors usually het-
erodimerize with retinoid receptor, whose ligand 
is derived from another dietary chemical, vitamin 
A, and hyperforin, bind directly to nuclear re-
ceptors and influence gene expression (Table 1). 
The liver X receptor-α (binding cholesterol me-
tabolites), bind as a heteromers to specific nu-
cleotide sequence (response elements) in the pro-
moter regions of a large member of genes. During 
ligand binding, nuclear receptors undergo a con-
formational change that results in coordinated dis-
sociation of corepressors and recruitment of coac-
tivator proteins to prepare transcriptional activation 
(41). Thereby, a number of genes are induced 
such as those involved in fatty acid oxidation or 
fatty-acid storage, depending on the cellular meta-
bolic state (31). In metabolically active organs, 
such as the liver, intestine, and adipose tissue, 
these TFs act as nutrient sensors by changing the 
level of DNA transcription of specific genes in 
response to nutrients changes (41).  
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Table 1: Nuclear receptors and dietary ligands. Umbers in parentheses indicate percent activity after ligand binding rela-
tive to estradiol (36, 37, 50, 52, 53) 
 
Regulation Receptor Type Endogenous ligand Dietary ligand 
Endocrine: hormonal lipids:  
feedback paradigm 
Estrogen 
ERα 
ERβ 
 
 
17β-Esteradiol (100) 
17β-Esteradiol (100) 
Progestrone 
 Progestrone  Testoterone 
 Androgen  5α -dihydrotestosterone 
 Androgen  Aldosterone 
 Glucocorticoid  Cortisol 
Genisteine (4) 
 
 
Genisteine (87) 
 
Endogenous metabolism 
cholestrol precursor 
Mixed paradigm Retinoic acid 
RARα 
RARβ 
RARγ 
All-trans retinoic acid 
All-trans retinoic acid 
All-trans retinoic acid 
Vitamin A 
Vitamin A 
Vitamin A 
 Thyroid 
TRα 
TRβ  
Iodine 
Iodine 
 Vitamin D  1,25-dihydroxyvitamin D Vitamin D/Sunshine 
 Ecdisone  Cholesterol derivatives Cholesterol 
Lipid sensors: dietary lipids: 
feed-forward paradigm Retinoid X  C is-9-retinoic acid Docsahexaenoic acid 
 PPAR 
PPARα 
PPARβ 
PPARδ 
FA 
FA/eicosanoids 
? 
Pristinic/phytanic 
Pristinic/phytanic 
 Pregnan X  
Estrogen                             
Progesterone   Progesterone 
Hyperforin 
Coumesterol 
Genisteine 
 Liver X  Oxysterols Cholesterol metabolites 
 Famosoid X  Bile acids  
 
Dietary chemicals indirectly regulate some of 
TFs. The sterol regulatory element binding pro-
teins (SREBPs), for example, are activated by 
protease cleavage, an event regulated by low 
levels of oxy sterols and changes in insulin/ 
glucose and PUFAS (49). The carbohydrate-re-
sponsive element-binding protein (chREBP) is a 
large TF, activated in response to high glucose 
levels, and is regulated by reversible phosphoryla-
tion events (50). This DNA binding protein serves 
as an effector of lipogenic gene expression (51). 
Moreover, dietary chemicals can directly affect 
signal transduction pathways. For example, green 
tea contains the polyphenol, 11-epigallocatechin-3-
gallate (EGCG) that EGCG inhibits tyrosine 
phosphorylation of Her-2/neu receptor and epi-
dermal growth factor receptor that reduces sig-
naling via the phosphatidyl inositol 3-kinase (PI-
3)-AKt kinase-NF-kB pathway. Activation of the 
NF-kB pathway is associated with some types of 
breast cancer (50, 52, 53). 
PUFAs such as n-3 and n-6 are other micronutri-
ents, which are also referred to as omega-3 and 
omega-6 fatty acids, may influence gene expres-
sion. Animal studies have demonstrated that PUFA 
intake can modulate the gene expression of sev-
eral enzymes involved in lipid and carbohydrate 
metabolism. A significant interaction has also been 
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shown for the PPARA Lue162Val polymorphism 
n-6 PUFA intake. Individuals with the less com-
mon V162 allele, increased n-6 PUFA intake is 
associated with a marked reduction in triacylglyc-
erol concentration, whereas this association is 
not observed in L162 carriers. Conversely, in 
L162 and V162 carriers n-3 PUFA intakes results 
in triacylglycerol concentrations reduction (32). 
Approximately 40 micronutrients are needed in 
the human diet. Suboptimal intakes of specific 
micronutrients have been associated with CVD 
(Vit B, E, and carotenoids), cancer (folate, 
carotenoids), neural tube defects (folate), and 
bone mass (Vit D) (54). B6, B12 and folate defi-
ciencies, for example, are associated with in-
creased serum homocysteine levels. Hyperho-
mocysteinemia is a risk factor and marker for 
coronary artery disease. Deficiency of Vit B12, 
folic acid, B6, niacin, C or E, iron or zinc 
appears to imitate radiation in damaging DNA 
by causing single and double-strand breaks, 
oxidative lesions, or both (55), (Table 2).  
 
Table 2: Examples of the role and effect of specific micronutrients deficiencies on genomic stability (56, 57) 
 
Micronutrients Role in genomic stability Consequence of  deficiency 
Vits C and E Prevention of DNA and lipid oxidation. 
Vit D 
Antioxidant activity by increasing glutathione level in 
normalm cell, inducuction apoptosis   in cancer cells. 
Increased baseline level of DNA strand 
breaks, chromosome breaks,    oxidative 
DNA lesions and    lipid peroxide adducts 
on DNA. 
Folate and 
Vits B2, B6, B12 
Maintenance methylation of DNA, synthesis of dTMP 
from dUMP and efficient recycling of folate. 
uracil misincorporation in DNA, increased    
chromosome breaks and DNA 
hypomethylation. 
Niacin, Nicotinic acid 
Required as substrate for poly (ADP- ribose) 
polymerase which is involved  in cleavage and 
rejoining of DNA and telomere length 
Maintenance and DNA repair. 
Increased level of unrepaired nicks in DNA, 
increased chromosome breaks and 
rearrangement, sensitivity of mutagens. 
Zinc, Manganese and 
Selenium 
Zn, required as a cofactor for Cu/Zn supperoxid 
dismutase, endonuclease IV, P53 function, DNA 
replication and Zinc finger proteins such as poly (ADP- 
ribose) polymerase. 
Mn, required as a component of                                      
mitochondrial Mn superoxide dismutase.                                      
Se, required as a component of peroxidases e.g. 
glutathione peroxidase. 
Increased DNA breaks and oxidation, 
elevated    chromosomal damage rate. 
Iron Required as a component of ribonucleotide reductase 
and mitochondrial cytochromes. 
Reduced DNA repair capacity, increased 
propensity for oxidative damage to 
mitochondrial DNA. 
Magnesium, Calcium 
Mg, required as a cofactor for a variety of   DNA 
polymerases, in nucleotide excision   Repaire, base 
excision repair and mismatch   Repair, essencial for 
microtubule Polymerization and chromosome 
segregation.   Ca, plays an important role in 
chromosome    Segregation and is required for 
apoptosis. 
Reduced fidelity of DNA replication, 
reduced DNA repaire capacity, 
chromosome segregation Errors,survival of  
genomically aberrant cells. 
 
 
 
Nutrient deficiencies are more important than 
radiation because of constancy of exposure to 
milieu promoting DNA damage (58-60). For 
example, folate deficiency breaks chromosomes 
due to substantial incorporation of uracil in hu-
man DNA (4 million uracil/cell) (61).  
Amino acids can play the role of nutritional sig-
nals in the modulation of expression of particu-
lar genes. Studies have shown that cells can de-
tect variants in amino acid levels and respond by 
mechanism as control of transcription, mRNA 
stabilization ,as well as by up or down  regulation 
 9 
of translation initiation (62). For example, in 
human cells amino acid L-tryptophan in supra-
physiologic concentrations is a powerful inducer 
of collagenase gene expression at a transcrip-
tional level. The increase in collagenase mRNA 
levels was reversible, time and L-tryptophan dose-
dependent (63). 
Simple and complex carbohydrates have differen-
tial effects on blood glucose concentrations. Foods 
with a high glycemic index (GI) would increase 
insulin production and, decrease synthesis of insu-
lin receptors. High glucose concentration also 
induces the transcription of several genes of the 
glycolytic and lipogenic pathways (64). 
Therefore, dietary chemicals are regularly ingested 
and are involved indirectly and directly in regu-
lation gene expression, it follows that a subset of 
genes regulated by diet must be involved in disease 
initiation, progression, and severity (65, 66).  
 
Nutritional epigenetics  
The term "epigenetics" is used to gene expres-
sion that occurs without changes in the DNA se-
quence. Epigenetic regulation plays an impor-
tant role in development and is needed to gain 
stable expression or repression of genes in spe-
cific cell types or at defined developmental stages 
(67). Epigenetic changes may influence cell cycle 
control, DNA damage, apoptosis, invasion, im-
printing, and aging (8). 
Epigenetic events can be modified by bioactive 
food components (Table 3).  
 
Table 3: Some nonessential nutrients and bioactive food 
components that can alter genetic and epigenetic events (8) 
 
Nutrient group Example 
Phytochemicals 
Isothiocyanates, allyl sulfur 
Carotenoids, flavonoids, indoles, 
Zoochemicals Conjugated linoleic acid, n-3 fatty acids 
Fungochemicals 
β-glucans, lentinan, schizophylan, and 
other compounds in mushrooms. 
Bacteriochemicals 
Equol, butyrate, and other compounds 
formed from gastrointestinal flora 
fermentation 
 
A majority of regulatory proteins including DNA 
methyltransferases, methyl-cytosine guanine dinu-
cleotide binding proteins, histon-modifing enzymes, 
chromatin-remodeling factors, and their multi-
molecular complexes are involved in the overall 
epigenetic process (8). The best studied epige-
netic modification is DNA methylation and in the 
mammals genome occurs at many of cytosine 
residues that are followed by guanine residue 
(CpG islands) and in most cases methylation in 
these regions induces gene repression. However, 
this phenomenon can lead to the expression of 
neighboring genes (67). Studies identify that DNA 
methylation is dependent on bioactive food com-
ponents ranging from alcohol to zinc (8) (Table 4).  
 
Table 4: Nutrients and chemicals involved in DNA 
methylation (8, 68) 
 
Micronutrients 
Alcohol Genistein 
Arsenic Methionine 
Betaine Nickel 
Cadmium Polyphenol 
Choline Selenium 
Coumestrol Vitamin A 
Equol Vitamin B6 
Fiber VitaminB12 
Folate Zinc 
 
Several dietary factors may influence the provi-
sion of methyl groups available for the formation 
of S-adenosylmethinine. Moreover, dietary factors 
may modulate the use of methyl group by proc-
esses including change in DNA methyltransferase 
activity. The methyl groups’ status depends on 
B vitamins as cofactors including folate, Vit B12, 
and Vit B6 (29). The folate-dependent biosyn-
thesis of nucleotide precursors for DNA synthe-
sis and of SAM for genome methylation is de-
pendent on the availability of many vitamins in-
cluding B12, B6, niacin, riboflavin and minerals 
(zinc, cobalt). Therefore, folate-mediated one-
carbon metabolism mediates communication be-
tween the cellular nutrient environment and regula-
tion of the genome. Impairments in one-carbon 
metabolism and the SAM cycle induced by nu-
tritional deficiencies and/or SNPs in genes that 
encode folate-dependent enzymes, alter genome 
methylation patterns and gene expression levels. 
Disruptions in folate metabolism are common and 
increase risk cancers, cardiovascular disease, neu-
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rological disorders and developmental anomalies 
such as spina bifida, cleft palate, and spontaneous 
abortion. Therefore, folate supplementation can re-
duce the risk of these disorders developing (69). 
DNA methylation patterns may effect on the re-
sponse to bioactive food components and thereby 
account for differences in response in normal and 
neoplastic cells (70). 
 
Genome health and disease prevention 
It is clear that even the small damages in the ge-
nome can cause crucial effects in whole human 
life. DNA metabolism and repair is depending 
on a variety of dietary factors that act as cofac-
tors or substrates. Nutritional requirements is 
important for the prevention of DNA oxidation 
(i.e. antioxidants such as carotenoids, Vit E and 
C), prevention of uracil incorporation into DNA 
(i.e. folate), maintenance methylation of CpG in 
DNA (methionine, cholin, folate and vitamin 
B12), as cofactors or as components of DNA re-
pair enzymes (Zn, Mg), maintenance of telomere 
length (niacin, folate) (56, 69, 70).  
Many chronic diseases are polygenic and result 
from interaction between genes and environ-
mental factor. Dietary intervention based on nutri-
tional requirement, nutritional status, and genotype 
(i.e., “individualized nutrition"), can be used to pre-
vent, control or treatment of chronic disease such 
as cardiovascular diseases (CVD), metabolic syn-
dromes, and cancer (41). These disorders are 
partly mediated by chronic exposure to certain 
food components. Fore example, the association 
between amount of calories (35), the levels and 
types of vitamins (71), fat (72), and carbohydrates 
with atherosclerosis, diabetes, obesity, cancer, 
hypertension, and other chronic diseases is dem-
onstrated (73).  
 
Genome damage and nutritional deficiency 
As mentioned earlier, nutritional status influences 
genome stability and deficiency of certain mic-
ronutrients can result in critical damages in the 
genome. Studies have shown that at least nine 
micronutrients (Vit E, Ca, folate, retinol, nico-
tinic acid, β-caroten, riboflavin, pantothenic acid, 
and biotin) affect genome stability in human in 
vivo (4). Folate and vitamin B12 are need for 
DNA replication, repair and maintenance of 
DNA methylation patterns. Both in vivo and in 
vitro studies with human cells clearly show that 
folate and vitamin B12 deficiencies and elevated 
plasma homocysteine are associated with the 
expression of chromosomal fragile sites, chromo-
somal breaks, excessive uracile in DNA and DNA 
hypomethylation. Nicotinic acid (niacin) also plays 
a fundamental role in chromosome integrity and 
reduction of cancer risk (Table 2) (70).  
Reactive oxygen species (ROS) such as highly 
reactive hydroxyl radical and superoxide radical 
contributes to DNA damage. Antioxidants (Vit 
C and E) and enzymes such as superoxid dismu-
tase, catalase and glutathionperoxidase may con-
trol lipid and protein oxidation induced by ROS (3).  
Since developmental, degenerative diseases and 
aging are partly caused by DNA damage, defin-
ing optimal requirements of key minerals and 
vitamins for preventing nuclear and mitochon-
drial DNA damage is important (70).  
Infertility is another consequence of genome dam-
age on human health. Genome damage results 
from specific micronutrient deficiencies may cause 
developmental defects in the fetus or increased 
risk of cancer in the child. For example, inadequate 
Vit C intake results in increased oxidation of 
sperm DNA; folate deficiency increases risk of 
NTDs and genome damage. Increased risk of 
childhood leukemia in children with mothers who 
did not intake enough folic acid supplementation 
during pregnancy has demonstrated. Additionally, 
zinc deficiency induces oxidative damage to DNA 
and impairs DNA repair, which has a terato-
genic effects (70, 74). 
 
Telomere and nutritional status 
Telomeres are nucleoprotein structures that cap 
the ends of chromosomes, and maintain chromo-
some stability. Degeneration of telomeres leads 
to whole chromosomal instability, and chromo-
somal fusion and therefore gene amplification, 
an important risk factor for cancer (3). Folate 
and nicotinic acid deficiency increased oxidative 
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stress and telomere dysfunction. Under folate 
deficiency uracil is incorporated into DNA in-
stead of thymidine, leading to chromosome break-
age. Similarly, oxidative stress causes telomere 
shortening. Folate and other methyl donors such 
as Vit B12, cholin, and methionin have an im-
portant role in maintenance methylation of cyto-
sine. Defects in the DNA methylation can cause 
excessive telomere elongation and homologous 
recombination between telomeres and telomeres 
fusion. Hypomethylation or hypermethylation of 
the CpG islands is in the promoter of telomerase 
may cause excessive expression of telomerase or 
silence the gene respectively (3). 
Telomere shortening has been observed in num-
ber of conditions including obesity, psychologi-
cal stress, immune dysfunction, cancer, and 
CVD. In vitro studies antioxidant treatment has 
been found to prevent telomere damage (3). 
 
Conclusions    
Nutritional genomics elucidate the interaction among 
nutrients, metabolic intermediates, and the mam-
malian genome. The response to bioactive food 
components is dependent on genetic background 
(Nutrigenetics effects) that can influence absorp-
tion and metabolism targets or sites of action. 
Likewise, the response to food components de-
pends on DNA methylation and other epigenetic 
events. The ability of bioactive food components 
to influence gene expression patterns (nutrigenom-
ics effects) is also a factor in determining the 
overall response. Finally, bioactive food compo-
nents may influence protein synthesis, degrada-
tion, and posttranslational modification. Under-
standing the interrelationships among human ge-
netics diversity, genome function, and dietary com-
ponents will enable precise manipulation of genome 
function and stability throughout the life cycle for 
optimal human health and disease prevention. 
With greater insight in to the gene-nutrient inter-
action, alterations in diet and single nutrient inter-
ventions may help us to better protect against can-
cer, decrease the occurrence of cardiovascular and 
other chronic diseases, and perhaps increase hu-
man longevity. 
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